Bremelanotide for Treatment of Female Hypoactive Sexual Desire

Bremelanotide for Treatment of Female Hypoactive Sexual Desire

Hypoactive sexual desire disorder (HSDD) is a persistent deficiency or absence of sexual fantasies and desire resulting in significant distress or interpersonal difficulty. Women with this disorder may display a lack of motivation for sexual activity, reduced responsiveness to erotic cues, a loss of...

Full description

Bibliographic Details
Main Authors: Amber N. Edinoff, Nicole M. Sanders, Kyle B. Lewis, Tucker L. Apgar, Elyse M. Cornett, Adam M. Kaye, Alan D. Kaye
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Neurology International
Subjects:
hypoactive sexual desire disorder
bremelanotide
melanocortin receptor agonist
Online Access:https://www.mdpi.com/2035-8377/14/1/6

Internet

https://www.mdpi.com/2035-8377/14/1/6

Similar Items